PUBLIC CONTRACT · 2024
Aquisição do medicamento epoetina beta 30000 u.i., dupilumab e ibrutinib para a ulscb E.P.E.
- Contract value
- €60,126.12
- Signed on
- 30 September 2024
- Procedure
- Open procedure (Concurso público)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 10950532PUBLISHED SUBJECT
AQUISIÇÃO DO MEDICAMENTO EPOETINA BETA 30000 U.I., DUPILUMAB E IBRUTINIB PARA A ULSCB E.P.E.
Parties involved
- Place of performance
- Portugal
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- JANSSEN-CILAG FARMACÊUTICA, LDA · Tax ID 500189412
- Bidder
- Sandoz Farmacêutica, Lda · Tax ID 506985261
- Bidder
- SANOFI - AVENTIS - PRODUTOS FARMACÊUTICOS, S. A. · Tax ID 500134960
- Bidder
- ROCHE FARMACÊUTICA E QUÍMICA, LDA. · Tax ID 500233810
Values and timeline
- Contract price
- €60,126.12
- Procedure base price
- €162,564.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 3 October 2024
- Award date
- 13 September 2024
- Signing date
- 30 September 2024
- Performance period
- 151 days
The contract price is the value agreed in the contract, not the amount paid.
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Open procedure (Concurso público)
- Award criterion
- Multifator
- CPV code
- 33690000-3 - Medicamentos vários
- Legal basis
- Artigo 20.º, n.º 1, alínea b) do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
- Framework agreement
- Not stated
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- 16452/2024
- Procedure identifier
- 7189709
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.